Improved binding of SARS-CoV-2 Envelope protein to tight junction-associated PALS1 could play a key role in COVID-19 pathogenesis

Abstract

The Envelope (E) protein of SARS-CoV-2 is the most enigmatic protein among the four structural ones. Most of its current knowledge is based on the direct comparison to the SARS E protein, initially mistakenly undervalued and subsequently proved to be a key factor in the ER-Golgi localization and in tight junction disruption. We compared the genomic sequences of E protein of SARS-CoV-2, SARS-CoV and the closely related genomes of bats and pangolins obtained from the GISAID and GenBank databases. When compared to the known SARS E protein, we observed a significant difference in amino acid sequence in the C-terminal end of SARS-CoV-2 E protein. Subsequently, in silico modelling analyses of E proteins conformation and docking provide evidences of a strengthened binding of SARS-CoV-2 E protein with the tight junction-associated PALS1 protein. Based on our computational evidences and on data related to SARS-CoV, we believe that SARS-CoV-2 E protein interferes more stably with PALS1 leading to an enhanced epithelial barrier disruption, amplifying the inflammatory processes, and promoting tissue remodelling. These findings raise a warning on the underestimated role of the E protein in the pathogenic mechanism and open the route to detailed experimental investigations.

Hemorrhagic and ischemic stroke in patients with coronavirus disease 2019: incidence, risk factors, and pathogenesis - a systematic review and meta-analysis

“…Another study reported that VE-cadherin, the major transmembrane protein of AJ, connected to Pals1 during the formation of vascular lumen indicating the specific role of this polarity protein in regulating junctional formation in endothelial cells 106 . Interestingly, SARS-CoV-2 has been suggested to interact with the Pals1 protein in host cells through its envelope (E) protein 107 . A study demonstrated that another betacoronavirus—SARS—also uses this mode of interaction with host cells 108 .…”

A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic

“…The viral spike glycoprotein has a receptor-binding domain (RBD) for the interaction with host cell receptors (45).The membrane glycoprotein is responsible for the assembly of viral particles (46). The envelope protein is reported to play a role in pathogenesis as it interacts with the tight junction related protein, named; Protein Associated with Caenorhabditis elegans Lin-7 protein 1 (PALS1) (47). The nucleocapsid protein, which is a phosphoprotein, packs the viral genome into a ribonucleoprotein complex and plays a role in viral genome replication and the cell-signaling pathway (48).…”

Impact of Clinical and Genomic Factors on SARS-CoV2 Disease Severity

“…Focusing on the significant biomarkers from the combined model, we observed two new GO enriched terms, passive transmembrane transporter activity and PDZ domain binding (Figure 5(b)). It has been shown that PDZ-containing proteins among binders of the SARS-CoV-2 proteins E, 3a or N affect viral replication under knock-down gene expression in infected cells, significantly 27 , particularly in the E protein 28 .…”